PMC:7212949 / 4744-4997 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":65,"end":71},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma228738"}],"text":"%)\n• Spontaneous pneumomediastinum (12%) during follow-up\n• Sore throat (11%)\n• Shortness of breath (4%)\n• O2 saturation \u003c 90% on room air (44mean 9.1 days after symptom onset)\nKey findings on investigations CXR• Consolidation (78.3% at fever onset, eve"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T8","span":{"begin":65,"end":71},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_0000341"}],"text":"%)\n• Spontaneous pneumomediastinum (12%) during follow-up\n• Sore throat (11%)\n• Shortness of breath (4%)\n• O2 saturation \u003c 90% on room air (44mean 9.1 days after symptom onset)\nKey findings on investigations CXR• Consolidation (78.3% at fever onset, eve"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T36","span":{"begin":60,"end":71},"obj":"Disease"}],"attributes":[{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0002258"}],"text":"%)\n• Spontaneous pneumomediastinum (12%) during follow-up\n• Sore throat (11%)\n• Shortness of breath (4%)\n• O2 saturation \u003c 90% on room air (44mean 9.1 days after symptom onset)\nKey findings on investigations CXR• Consolidation (78.3% at fever onset, eve"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T20","span":{"begin":73,"end":75},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"%)\n• Spontaneous pneumomediastinum (12%) during follow-up\n• Sore throat (11%)\n• Shortness of breath (4%)\n• O2 saturation \u003c 90% on room air (44mean 9.1 days after symptom onset)\nKey findings on investigations CXR• Consolidation (78.3% at fever onset, eve"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":107,"end":109},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_15379"}],"text":"%)\n• Spontaneous pneumomediastinum (12%) during follow-up\n• Sore throat (11%)\n• Shortness of breath (4%)\n• O2 saturation \u003c 90% on room air (44mean 9.1 days after symptom onset)\nKey findings on investigations CXR• Consolidation (78.3% at fever onset, eve"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T23","span":{"begin":17,"end":34},"obj":"Phenotype"},{"id":"T24","span":{"begin":60,"end":71},"obj":"Phenotype"},{"id":"T25","span":{"begin":80,"end":99},"obj":"Phenotype"},{"id":"T26","span":{"begin":237,"end":242},"obj":"Phenotype"}],"attributes":[{"id":"A23","pred":"hp_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/HP_0025421"},{"id":"A24","pred":"hp_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/HP_0033050"},{"id":"A25","pred":"hp_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A26","pred":"hp_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/HP_0001945"}],"text":"%)\n• Spontaneous pneumomediastinum (12%) during follow-up\n• Sore throat (11%)\n• Shortness of breath (4%)\n• O2 saturation \u003c 90% on room air (44mean 9.1 days after symptom onset)\nKey findings on investigations CXR• Consolidation (78.3% at fever onset, eve"}

{"project":"LitCovid-sentences","denotations":[{"id":"T43","span":{"begin":3,"end":57},"obj":"Sentence"},{"id":"T44","span":{"begin":58,"end":77},"obj":"Sentence"},{"id":"T45","span":{"begin":78,"end":104},"obj":"Sentence"},{"id":"T46","span":{"begin":105,"end":176},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"%)\n• Spontaneous pneumomediastinum (12%) during follow-up\n• Sore throat (11%)\n• Shortness of breath (4%)\n• O2 saturation \u003c 90% on room air (44mean 9.1 days after symptom onset)\nKey findings on investigations CXR• Consolidation (78.3% at fever onset, eve"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T64","span":{"begin":65,"end":71},"obj":"UBERON:0000341"},{"id":"T65","span":{"begin":93,"end":99},"obj":"UBERON:0002048"},{"id":"T66","span":{"begin":107,"end":109},"obj":"CHEBI:15379;CHEBI:15379"},{"id":"T469","span":{"begin":6,"end":13},"obj":"CHEBI:33695;CHEBI:33695"},{"id":"T470","span":{"begin":143,"end":150},"obj":"UBERON:0000948"},{"id":"T471","span":{"begin":191,"end":198},"obj":"UBERON:0000948"},{"id":"T472","span":{"begin":207,"end":212},"obj":"G_3;PG_10"}],"text":"%)\n• Spontaneous pneumomediastinum (12%) during follow-up\n• Sore throat (11%)\n• Shortness of breath (4%)\n• O2 saturation \u003c 90% on room air (44mean 9.1 days after symptom onset)\nKey findings on investigations CXR• Consolidation (78.3% at fever onset, eve"}